Cardiff Oncology, Inc. (CRDF) Discusses Updated Phase II CRDF-004 Data on Onvansertib in First-Line RAS-Mutated Metastatic Colorectal Cancer - Slideshow
Cardiff Oncology Inc CRDF
$1.21
▲ +2.54%
(+$0.03)
Open
$1.20
Prev Close
$1.18
Day Range
$1.20 – $1.29
52W Range
$1.16 – $4.56
Market Cap
$82.73M
Beta
1.44
EPS (TTM)
$-0.67
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2004-07-27 |
| Shares Out. | 68,370,000 |
| Website | cardiffoncology.com/ ↗ |
| Phone | 13026365400 |
Cardiff Oncology Inc is a publicly traded company under the ticker symbol CRDF on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
14 analysts (2026-06-01)